Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

59 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
IL-23/IL-17 immunity as a hallmark of Crohn's disease.
Hölttä V, Klemetti P, Sipponen T, Westerholm-Ormio M, Kociubinski G, Salo H, Räsänen L, Kolho KL, Färkkilä M, Savilahti E, Vaarala O. Hölttä V, et al. Among authors: sipponen t. Inflamm Bowel Dis. 2008 Sep;14(9):1175-84. doi: 10.1002/ibd.20475. Inflamm Bowel Dis. 2008. PMID: 18512248
Changes in matrix metalloproteinase (MMP) and tissue inhibitors of metalloproteinases (TIMP) expression profile in Crohn's disease after immunosuppressive treatment correlate with histological score and calprotectin values.
Mäkitalo L, Sipponen T, Kärkkäinen P, Kolho KL, Saarialho-Kere U. Mäkitalo L, et al. Among authors: sipponen t. Int J Colorectal Dis. 2009 Oct;24(10):1157-67. doi: 10.1007/s00384-009-0756-5. Epub 2009 Aug 4. Int J Colorectal Dis. 2009. PMID: 19652986
Endoscopic monitoring of infliximab therapy in Crohn's disease.
af Björkesten CG, Nieminen U, Turunen U, Arkkila PE, Sipponen T, Färkkilä MA. af Björkesten CG, et al. Among authors: sipponen t. Inflamm Bowel Dis. 2011 Apr;17(4):947-53. doi: 10.1002/ibd.21439. Epub 2010 Sep 21. Inflamm Bowel Dis. 2011. PMID: 20860048
59 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page